CEO Guo Weiping and CFO and Deputy General Manager Peng Jiahong

On 30th March 2016, Universal Medical Financial & Technical Advisory Services Company Limited ("Universal Medical" or "the Company"; stock code:2666) gives a press conference on 2015 annual results in Island Shangri-la, Hong Kong. On behalf of the management, CEO Guo Weiping and CFO and Deputy General Manager Peng Jiahong attend the press conference. 

The press conference of Universal Medical, a leading integrated healthcare services provider, has attracted over 150 investors, analysts and friends from the press. During the conference, the CEO Guo Weiping addresses to the participants on the Company’s operation results in 2015 and future prospects. The CFO Peng Jiahong presents the Company’s financial performance. In Q&A section, the management also answer the questions from investors and analysts.

Q&A Section

The management have a in-depth discussion on topics like the Company’s medical technology services capability, hospital investment and management business, medical resources platform establishment and future outlook, which receives wide recognition and thunderous applause from the participants. 

According the annual results released on 29th March, 2016, for the year ended 31 December 2015, the Company realized a revenue of RMB2,193 million, representing an increase of RMB641 million or 41.3% as compared to the previous year. Profit before tax amounted to approximately RMB900 million, representing an increase of RMB289 million or 47.3% as compared to the previous year. The Company’s gross profit was RMB1,309 million, increasing by RMB375 million or 40.2% as compared to last year. 

In particular, interest margin gross profit of finance lease business was RMB598 million, representing an increase of RMB162 million or 37.2% as compared to last year; gross profit of industry, equipment and financing advisory services was RMB586 million, representing an increase of RMB144 million or 32.5% as compared to last year; gross profit of clinical department upgrade services was RMB123 million, representing an increase of RMB67.89 million or 123.5% as compared to last year, and its gross profit as a percentage of total gross profit has increased from 5.9% in 2014 to 9.4% due to the consistent improvement of the Company’s medical technology services.

The management state, In the years to come, based on the guidance and support of national policies, the Company will firmly seize the golden opportunities in China’s healthcare and elderly care market, focus on becoming a leading integrated healthcare services provider, constantly reinforce the Company’s operating base, expand the Company’s medical resources platform, steadily develop the Company’s medical financing services, and make it the Company’s steadily growing profit source and its cornerstone for innovation. The Company will actively promote the its medical technology services with a focus on clinical department upgrade, and make it the Company’s incubator of new profit source; vigorously advance the Company’s hospital investment management business, and make it the Company’s driving force of the rapid growth of its results. The Company will develop hospital digitalization services in a collaborative manner and contribute to the development of the cooperative hospitals that the Company invested and managed.